Your browser doesn't support javascript.
loading
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes.
Wang, Yi Kan; Bashashati, Ali; Anglesio, Michael S; Cochrane, Dawn R; Grewal, Diljot S; Ha, Gavin; McPherson, Andrew; Horlings, Hugo M; Senz, Janine; Prentice, Leah M; Karnezis, Anthony N; Lai, Daniel; Aniba, Mohamed R; Zhang, Allen W; Shumansky, Karey; Siu, Celia; Wan, Adrian; McConechy, Melissa K; Li-Chang, Hector; Tone, Alicia; Provencher, Diane; de Ladurantaye, Manon; Fleury, Hubert; Okamoto, Aikou; Yanagida, Satoshi; Yanaihara, Nozomu; Saito, Misato; Mungall, Andrew J; Moore, Richard; Marra, Marco A; Gilks, C Blake; Mes-Masson, Anne-Marie; McAlpine, Jessica N; Aparicio, Samuel; Huntsman, David G; Shah, Sohrab P.
Afiliación
  • Wang YK; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Bashashati A; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Anglesio MS; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Cochrane DR; Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Grewal DS; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Ha G; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • McPherson A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Horlings HM; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Senz J; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Prentice LM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Karnezis AN; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Lai D; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Aniba MR; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Zhang AW; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Shumansky K; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Siu C; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Wan A; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • McConechy MK; Graduate Bioinformatics Training Program, University of British Columbia, Vancouver, British Columbia, Canada.
  • Li-Chang H; Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Vancouver, British Columbia, Canada.
  • Tone A; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Provencher D; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • de Ladurantaye M; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Fleury H; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Okamoto A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Yanagida S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Yanaihara N; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Saito M; Institut du Cancer de Montréal, Montreal, Quebec, Canada.
  • Mungall AJ; Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada.
  • Moore R; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Marra MA; Institut du Cancer de Montréal, Montreal, Quebec, Canada.
  • Gilks CB; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Mes-Masson AM; Institut du Cancer de Montréal, Montreal, Quebec, Canada.
  • McAlpine JN; Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
  • Aparicio S; Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
  • Huntsman DG; Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
  • Shah SP; Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
Nat Genet ; 49(6): 856-865, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28436987
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Reparación del ADN Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Reparación del ADN Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Canadá